Skip to main content
Clinical Trials/NCT06667830
NCT06667830
Completed
Not Applicable

A Comparative Study of Two Different Physical Exercise Programs to Improve Pain, Functional Status, and Physical Performance in Older Adults With Chronic Musculoskeletal Pain: a Randomized Controlled Trial

Aveiro University2 sites in 1 country70 target enrollmentOctober 31, 2024

Overview

Phase
Not Applicable
Intervention
Physical exercise program
Conditions
Chronic Musculoskeletal Pain
Sponsor
Aveiro University
Enrollment
70
Locations
2
Primary Endpoint
Pain Severity
Status
Completed
Last Updated
2 months ago

Overview

Brief Summary

The goal of this clinical trial is to evaluate the effectiveness of a multimodal physical exercise program for older adults (> 60 years) with chronic musculoskeletal pain. The main question it aims to answer is:

What is the impact of the intervention program on participants´ pain intensity (primary outcome), function, physical performance, and somatosensory function (secondary outcomes)? Participants will be assessed at 3 different moments: initial assessment (T0), at the end of the intervention protocol (10 weeks) (T1) and 3 months after the end of the intervention protocol (T2). The intervention protocol will consist of a multimodal exercise program to be carried out over a period of 10 weeks at a frequency of twice a week.

Registry
clinicaltrials.gov
Start Date
October 31, 2024
End Date
February 27, 2026
Last Updated
2 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Aveiro University
Responsible Party
Principal Investigator
Principal Investigator

Frederico Mesquita Baptista

Principal Investigator

Aveiro University

Eligibility Criteria

Inclusion Criteria

  • Community-dwelling older adults aged 60 years or older
  • People with primary or secondary chronic musculoskeletal pain in any body site
  • People able to walk independently

Exclusion Criteria

  • Individuals undergoing surgery in the last 3 months
  • Patients with a self-reported diagnoses of infection diseases, dementia, tumor/cancer, stroke, uncontrolled diabetes, or at high risk of developing cardiovascular events
  • Those with physical limitations that make it impossible for them to carry out the intervention protocols independently (e.g., wheelchair user)
  • Patients who are receiving another physical therapy intervention to treat their pain.

Arms & Interventions

Physical exercise

Intervention: Physical exercise program

Physical exercise + Neural mobilization

Intervention: Physical exercise program

Physical exercise + Neural mobilization

Intervention: Neural mobilization techniques

Outcomes

Primary Outcomes

Pain Severity

Time Frame: T0: baseline assessment; T1: 10 weeks (post-intervention assessment); T2: 3 months post-intervention (follow-up assessment)

Brief Pain Inventory - It assesses pain intensity and functional interference related to pain in the last week. In addition to these two main aspects, it also evaluates the location of the pain, the use of medications and the amount of pain relief in the last week. The instrument has 4 items relating to pain intensity in the last week and 7 items relating to the functional interference of pain with numerical rating scales (from 0 to 10) where higher values indicate greater pain severity. In situations where the participant reports musculoskeletal pain in more than one site, they will be asked to answer the questions considering their main chronic pain.

Secondary Outcomes

  • Temporal characteristics of pain(T0: baseline assessment; T1: 10 weeks (post-intervention assessment); T2: 3 months post-intervention (follow-up assessment))
  • Neuropathic pain components(T0: baseline assessment; T1: 10 weeks (post-intervention assessment); T2: 3 months post-intervention (follow-up assessment))
  • Pain Catastrophizing(T0: baseline assessment; T1: 10 weeks (post-intervention assessment); T2: 3 months post-intervention (follow-up assessment))
  • Fear of Movement(T0: baseline assessment; T1: 10 weeks (post-intervention assessment); T2: 3 months post-intervention (follow-up assessment))
  • Signs and symptoms of hypersensitivity of the nervous system(T0: baseline assessment; T1: 10 weeks (post-intervention assessment); T2: 3 months post-intervention (follow-up assessment))
  • Pressure Pain Threshold measured in three different sites (thenar region of the dominant hand; dorsum of foot on dominant side; region of greatest pain)(T0: baseline assessment; T1: 10 weeks (post-intervention assessment); T2: 3 months post-intervention (follow-up assessment))
  • Q-sense - Cold and Warm Perception Threshold (thenar region of the dominant hand; dorsum of foot on dominant side; region of greatest pain)(T0: baseline assessment; T1: 10 weeks (post-intervention assessment); T2: 3 months post-intervention (follow-up assessment))
  • Q-sense - Heat Pain Threshold (thenar region of the dominant hand; dorsum of foot on dominant side; region of greatest pain)(T0: baseline assessment; T1: 10 weeks (post-intervention assessment); T2: 3 months post-intervention (follow-up assessment))
  • Lower Limb Strength(T0: baseline assessment; T1: 10 weeks (post-intervention assessment); T2: 3 months post-intervention (follow-up assessment))
  • Grip Strength(T0: baseline assessment; T1: 10 weeks (post-intervention assessment); T2: 3 months post-intervention (follow-up assessment))
  • Balance(T0: baseline assessment; T1: 10 weeks (post-intervention assessment); T2: 3 months post-intervention (follow-up assessment))

Study Sites (2)

Loading locations...

Similar Trials